HK1096316A1 - X-ray visible drug delivery device - Google Patents

X-ray visible drug delivery device

Info

Publication number
HK1096316A1
HK1096316A1 HK07104069A HK07104069A HK1096316A1 HK 1096316 A1 HK1096316 A1 HK 1096316A1 HK 07104069 A HK07104069 A HK 07104069A HK 07104069 A HK07104069 A HK 07104069A HK 1096316 A1 HK1096316 A1 HK 1096316A1
Authority
HK
Hong Kong
Prior art keywords
delivery device
drug delivery
ray visible
visible drug
ray
Prior art date
Application number
HK07104069A
Other languages
English (en)
Inventor
Veenstra Harm
De Graaff Wouter
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34928916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1096316(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of HK1096316A1 publication Critical patent/HK1096316A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0404—X-ray contrast preparations containing barium sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Steroid Compounds (AREA)
HK07104069A 2004-03-19 2007-04-18 X-ray visible drug delivery device HK1096316A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101151 2004-03-19
PCT/EP2005/051150 WO2005089814A1 (en) 2004-03-19 2005-03-14 X-ray visible drug delivery device

Publications (1)

Publication Number Publication Date
HK1096316A1 true HK1096316A1 (en) 2007-06-01

Family

ID=34928916

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104069A HK1096316A1 (en) 2004-03-19 2007-04-18 X-ray visible drug delivery device

Country Status (33)

Country Link
US (1) US8722037B2 (xx)
EP (1) EP1729819B1 (xx)
JP (1) JP5055501B2 (xx)
KR (1) KR101086619B1 (xx)
CN (1) CN1953770B (xx)
AR (1) AR048106A1 (xx)
AT (1) ATE399569T1 (xx)
AU (1) AU2005224054B2 (xx)
BR (1) BRPI0508865B8 (xx)
CA (1) CA2559250C (xx)
CY (1) CY1108362T1 (xx)
DE (1) DE602005007873D1 (xx)
DK (1) DK1729819T3 (xx)
EC (1) ECSP066865A (xx)
EG (1) EG24359A (xx)
ES (1) ES2308460T3 (xx)
HK (1) HK1096316A1 (xx)
HR (1) HRP20080414T3 (xx)
IL (1) IL177970A (xx)
LV (1) LV13521B (xx)
MX (1) MXPA06010714A (xx)
MY (1) MY142649A (xx)
NO (1) NO338191B1 (xx)
NZ (1) NZ549877A (xx)
PE (1) PE20060022A1 (xx)
PL (1) PL1729819T3 (xx)
PT (1) PT1729819E (xx)
RU (1) RU2384347C2 (xx)
SI (1) SI1729819T1 (xx)
TW (1) TWI434676B (xx)
UA (1) UA86404C2 (xx)
WO (1) WO2005089814A1 (xx)
ZA (1) ZA200607602B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026111A2 (en) 2000-11-16 2004-04-01 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
US8900620B2 (en) 2005-10-13 2014-12-02 DePuy Synthes Products, LLC Drug-impregnated encasement
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
CA2916249C (en) 2013-06-21 2021-07-13 DePuy Synthes Products, Inc. Films and methods of manufacture
KR102272235B1 (ko) * 2016-05-12 2021-07-01 머크 샤프 앤드 돔 코포레이션 항바이러스제의 전달을 위한 약물 전달 시스템
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
EP3518896A4 (en) 2016-09-29 2020-08-05 Gesea Biosciences Inc. BIOERODABLE IMPLANT FOR LONG-TERM DRUG DELIVERY AND RELATED MANUFACTURING AND USE PROCEDURES
BR112020000320A2 (pt) * 2017-07-08 2020-07-14 Hera Health Solutions, Inc. implantes bioerodíveis de administração de fármacos
WO2019226516A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
CN119236191A (zh) 2018-05-24 2025-01-03 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8123912U1 (de) 1981-08-17 1982-01-14 B. Braun Melsungen Ag, 3508 Melsungen Sonde aus kunststoff
LU85320A1 (fr) 1984-04-17 1985-11-27 Oreal Composition cosmetique contenant de l'aloesine a titre d'agent de protection contre la lumiere solaire et son utilisation pour la protection de la peau et des cheveux
GB8430703D0 (en) * 1984-12-05 1985-01-16 Lrc Products Drug release devices
US4866132A (en) 1986-04-17 1989-09-12 The Research Foundation Of State University Of New York Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom
ES2054784T3 (es) * 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
ATE71543T1 (de) 1987-08-18 1992-02-15 Akzo Nv Injektionsvorrichtung fuer ein implantat.
JPH01178540A (ja) 1987-12-29 1989-07-14 Mitsubishi Cable Ind Ltd 医療用チューブ成形用組成物
US5141522A (en) * 1990-02-06 1992-08-25 American Cyanamid Company Composite material having absorbable and non-absorbable components for use with mammalian tissue
DE4320754A1 (de) 1993-06-23 1995-01-05 Hoechst Ag Vorrichtung zum Applizieren von Implantaten
GB9401577D0 (en) 1994-01-27 1994-03-23 Sheffield Orthodontic Lab Limi Polymer material suitable for the production of medical artifacts
US6162236A (en) * 1994-07-11 2000-12-19 Terumo Kabushiki Kaisha Trocar needle and expandable trocar tube
AU5025096A (en) 1995-02-27 1996-09-18 Instent Inc. Hollow stent
US6171326B1 (en) 1998-08-27 2001-01-09 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US6174329B1 (en) 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
BR9810180A (pt) 1997-06-20 2000-08-08 Akzo Nobel Nv Dispositivo de implantação
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
WO1999024490A1 (en) 1997-11-07 1999-05-20 Rutgers, The State University Strictly alternating poly(alkylene oxide ether) copolymers
US6159165A (en) 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
EP0938894A1 (en) 1998-02-16 1999-09-01 Biomat B.V. Implantable radiopaque device and use thereof
US6171297B1 (en) 1998-06-30 2001-01-09 Schneider (Usa) Inc Radiopaque catheter tip
DE29908415U1 (de) 1999-05-18 1999-07-22 Carl, Wolfgang, Dr.med.dent., 66386 St Ingbert Mittel zur Behandlung lokaler parodontaler Infektionen
DE19946606B4 (de) 1999-09-29 2013-07-04 Robert Bosch Gmbh Vorrichtung zum Bilden eines Kraftstoff-Luftgemischs für einen Verbrennungsmotor während einer Warmlaufphase
JP2003513938A (ja) 1999-11-09 2003-04-15 フォルシュングスツェントルム カールスルーエ ゲゼルシャフト ミット ベシュレンクテル ハフツング 希土類を含有している混合物及びその使用
FR2803304B1 (fr) * 1999-12-29 2006-03-24 Ceca Sa Inhibiteurs de depots inorganiques, notamment dans les puits petroliers
US6355058B1 (en) 1999-12-30 2002-03-12 Advanced Cardiovascular Systems, Inc. Stent with radiopaque coating consisting of particles in a binder
DE10004832A1 (de) * 2000-01-31 2001-08-16 Ethicon Gmbh Flächiges Implantat mit röntgensichtbaren Elementen
SE0000363L (sv) 2000-02-04 2001-08-05 Zoucas Kirurgkonsult Ab Belagd medicinsk anordning
FI20000572A (fi) 2000-03-13 2001-09-14 Leiras Oy Implantaattien asettamiseen tarkoitettu laite
DE10014518A1 (de) 2000-03-23 2001-10-04 Aventis Pharma Gmbh Vorrichtung zum Applizieren von Implantaten
JP2004516051A (ja) 2000-11-21 2004-06-03 シエーリング アクチエンゲゼルシャフト 管状血管移植片（ステント）およびその製造法
US20020138136A1 (en) 2001-03-23 2002-09-26 Scimed Life Systems, Inc. Medical device having radio-opacification and barrier layers
JP4901021B2 (ja) 2001-06-06 2012-03-21 川澄化学工業株式会社 カテーテルチューブ
US6911219B2 (en) * 2001-09-27 2005-06-28 Surgica Corporation Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7214206B2 (en) 2003-04-03 2007-05-08 Valera Pharmaceuticals, Inc. Implanting device and method of using same
DE10355087A1 (de) 2003-11-24 2005-06-09 Basf Ag Verfahren zur elektrochemischen Herstellung eines kristallinen porösen metallorganischen Gerüstmaterials
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
UA88674C2 (ru) 2005-01-24 2009-11-10 Н.В. Органон Аппликатор для введения имплантата
ES2829626T5 (es) 2005-01-24 2024-03-18 Merck Sharp & Dohme Aplicador para insertar un implante
USD551759S1 (en) 2005-06-13 2007-09-25 N. V. Organon Applicator for inserting an implant
EP1984063B1 (en) 2006-01-19 2019-08-14 Merck Sharp & Dohme B.V. Kit for and method of assembling an applicator for inserting an implant

Also Published As

Publication number Publication date
SI1729819T1 (sl) 2008-12-31
BRPI0508865B1 (pt) 2018-07-10
US8722037B2 (en) 2014-05-13
TW200534838A (en) 2005-11-01
KR20070027530A (ko) 2007-03-09
RU2006136913A (ru) 2008-04-27
JP2007529469A (ja) 2007-10-25
NZ549877A (en) 2009-07-31
ES2308460T3 (es) 2008-12-01
JP5055501B2 (ja) 2012-10-24
LV13521B (en) 2007-07-20
EP1729819A1 (en) 2006-12-13
BRPI0508865A (pt) 2007-09-04
CA2559250A1 (en) 2005-09-29
RU2384347C2 (ru) 2010-03-20
UA86404C2 (ru) 2009-04-27
PE20060022A1 (es) 2006-02-11
ZA200607602B (en) 2008-05-28
TWI434676B (zh) 2014-04-21
NO20064716L (no) 2006-11-28
NO338191B1 (no) 2016-08-01
EG24359A (en) 2009-03-04
HRP20080414T3 (en) 2008-09-30
AU2005224054B2 (en) 2009-12-17
MXPA06010714A (es) 2007-03-08
EP1729819B1 (en) 2008-07-02
IL177970A (en) 2010-12-30
CY1108362T1 (el) 2014-02-12
IL177970A0 (en) 2006-12-31
US20080112892A1 (en) 2008-05-15
CN1953770B (zh) 2011-10-12
AU2005224054A1 (en) 2005-09-29
CN1953770A (zh) 2007-04-25
MY142649A (en) 2010-12-15
ATE399569T1 (de) 2008-07-15
DK1729819T3 (da) 2008-10-20
AR048106A1 (es) 2006-03-29
PT1729819E (pt) 2008-10-02
BRPI0508865B8 (pt) 2021-05-25
CA2559250C (en) 2012-07-17
ECSP066865A (es) 2006-11-24
DE602005007873D1 (de) 2008-08-14
KR101086619B1 (ko) 2011-11-23
PL1729819T3 (pl) 2008-11-28
WO2005089814A1 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
EG24359A (en) x-ray visible drug delivery device
PL3437682T3 (pl) Urządzenie do podawania leków
GB0522569D0 (en) Biocompatible drug delivery device
IL169807A (en) Device for administering a drug
EP1804678A4 (en) ADMINISTRATIVE CATHETER FOR A MEDICAL DEVICE
GB0313604D0 (en) Delivery device for powdered medicament
EP1755732A4 (en) DISPENSING SYSTEM FOR MEDICINAL PRODUCTS IN SEVERAL SINGLE DOSES
HK1103520A1 (en) Medication delivery device
PL2058020T3 (pl) Urządzenie do podawania leków
IL174894A0 (en) Transdermal drug delivery device
EP1802258A4 (en) BIOSYNCHRONE TRANSDERMAL MEDICINES
EP1781355A4 (en) DEVICE FOR DELIVERY OF DRUGS
GB0402736D0 (en) A drug delivery device
EP1765158A4 (en) DISPENSER
GB2441474B (en) Dosage delivery device
EP1858493A4 (en) SYSTEM FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS
GB0401008D0 (en) Drug delivery system
IL185561A0 (en) Microject devices and methods for drug delivery
EP1765301A4 (en) PROSTHESIS DEVICE WITH MEDICINAL PROPERTIES
GB0405364D0 (en) Disposable drug delivery device
GB0403558D0 (en) Drug delivery
GB0409506D0 (en) Drug delivery
GB2410485B (en) Medicament delivery system
IL164189A0 (en) Ionized drug delivery device
TWI340043B (en) Oral drug delivery system